Don't Use Certain Tests for Pregnancy, Ovulation, UTIs, FDA Warns
Medically reviewed by Drugs.com.
By Cara Murez HealthDay Reporter
MONDAY, Aug. 14, 2023 – The U.S. Food and Drug Administration has warned that consumers should not use certain pregnancy, ovulation, urine, UTI and breast milk test kits over concerns that the tests may not be safe and effective.
The tests in question were manufactured by Universal Meditech Inc. (UMI), though they were branded under several names and may not include information about UMI on their packaging, the agency said in a news release.
The known distributors are AC&C Distribution LLC; HealthyWiser; Home Health US Inc. and Prestige Biotech Inc. The tests were sold under those brand names. UMI has notified the FDA that it has stopped all operations and is no longer providing support for its tests, the agency added.
The FDA could not confirm the performance of the company’s tests, which were sold online by at least these four distributors. The tests may also have been sold under other brand names by other distributors.
UMI recalled undistributed tests, but did not seek to recall tests that were already purchased.
Some of the names the tests were sold under include:
- One Step Pregnancy Test DiagnosUS One Step Ovulation Test
- HealthyWiser UriTest 10 Parameter Reagent Test Strips for Urinalysis
- HealthyWiser UriTest UTI Test Strips
- HealthyWiser KetoFast Ketone Test Strips
- HealthyWiser pH-Aware pH Test Strips
- To Life hCG Pregnancy Urine Test
- Am I Pregnant Pregnancy Midstream Test
- DeTec hCG Pregnancy Urine Test
- PrestiBio Pregnancy Strips
- PrestiBio Rapid Detection Pregnancy Test Midstream
- PrestiBio Ovulation Strips
- PrestiBio Urinalysis Test Strip 10 Parameters
- PrestiBio Ketone Test Strips
- PrestiBio Breast Milk Alcohol Test Strips
Consumers should not use or purchase these tests, the FDA said. They should immediately stop using and throw out these tests.
Someone who used one of these tests and still wants results can test again using a different test and consider discussing with a health care provider if you have concerns about the accuracy of your test results, the FDA said.
Report any adverse events or quality problems experienced with the use of these tests to the FDA's MedWatch Adverse Event Reporting program.
Sources
- U.S. Food and Drug Administration, news release, Aug. 11, 2023
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
Most Young Breast Cancer Survivors Can Have Children
FRIDAY, May 24, 2024 -- Most young breast cancer survivors can go on to have children despite the effects of their lifesaving treatment, a new study shows. About 73% of breast...
Scientists Discover Microplastics Abound in Human Testicles
WEDNESDAY, May 22, 2024 -- In a finding that suggests microplastics may pose a special danger to men, a new study has shown that human testicles contain these tiny bits of plastic...
Could Infertility Treatment Raise Postpartum Heart Risks?
MONDAY, May 20, 2024 -- Women treated for infertility were twice as likely as those who conceived naturally to be hospitalized with heart disease within a year of delivery, recent...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
